ArticleCancer science2007

Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma.

Wakae Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.